Biochemical pathology and treatment strategies in Alzheimer's disease: Emphasis on the cholinergic system

Authors

  • B. Winblad,

    1. Alzheimer's Disease Research Centre, Department of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. Fax +46-8-711 1751
    Search for more papers by this author
  • E. Messamore,

    1. Alzheimer's Disease Research Centre, Department of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. Fax +46-8-711 1751
    Search for more papers by this author
  • C. O'Neill,

    1. Alzheimer's Disease Research Centre, Department of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. Fax +46-8-711 1751
    Search for more papers by this author
  • R. Cowburn

    1. Alzheimer's Disease Research Centre, Department of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, S-141 86 Huddinge, Sweden. Fax +46-8-711 1751
    Search for more papers by this author

Abstract

The neurochemical pathology of Alzheimer's disease (AD) has been consistently shown to involve cholinergic degeneration in the cerebral cortex. This together with evidence from experimental animal studies showing that cholinergic neurones play a role in learning and memory processes has formed the basis of the cholinergic hypothesis of Alzheimer's dementia and the major rationale for neurotransmitter replacement therapy of the disorder.

Ancillary